Jayawardena Asitha D L, Fracchia M Shannon, Bartley Bethany L, Yonker Lael M, Lapey Allen, Virgin Frank, Hartnick Christopher J
Massachusetts Eye and Ear Infirmary, Department of Otolaryngology Head and Neck Surgery, Boston, MA, USA.
Massachusetts General Hospital, Department of Pediatric Pulmonology, Boston, MA, USA.
Int J Pediatr Otorhinolaryngol. 2020 Aug;135:110047. doi: 10.1016/j.ijporl.2020.110047. Epub 2020 May 5.
The prevalence of chronic rhinosinusitis (CRS), defined by mucosal thickening on imaging, approaches 100% in the cystic fibrosis (CF) population. CRS is associated with significant morbidity in CF, including its ability to trigger pulmonary exacerbations. CRS in CF is typically managed by pediatricians, otolaryngologists and pulmonologists. This survey evaluates the variance in practice patterns of CRS in CF amongst specialists.
This is a cross-sectional, electronic survey in which maximum variation purposive sampling was used by a multi-disciplinary group of pediatric, otolaryngology and pulmonology providers in order to select a survey population with expertise in CRS in CF patients. The survey was distributed to 381 practitioners from September to October 2019.
175 participants responded (45% response rate). Ten (of 54) statements achieved 75% consensus agreement. Consensus statements included: The decision to pursue surgical intervention for CRS in CF is a multi-disciplinary approach (94%; n = 146); maximal medical management should include nasal saline irrigation (93%; n = 142), topical steroids (75%; n = 117), maximal medical management should not include intravenous steroids (79%; n = 122); image guidance in surgery is necessary for all surgery involving the frontal sinuses (77%; n = 43), and all revision surgery(80%, n = 45); the appropriate setting for sinus surgery in a CF patient varies depending on patient presentation (89%; n = 133); post-operative regimen should include nasal saline (93%; n = 137); but does depend on the severity of disease discovered intra-operatively (84%; n = 124); post-operative antibiotics should be guided by intra-operative culture data (82%; n = 121).
There is a great deal of variation amongst specialists in the treatment of CRS in CF, however 10 statements met consensus criteria and should be considered when forming clinical care guidelines in this population.
根据影像学上的黏膜增厚定义,慢性鼻-鼻窦炎(CRS)在囊性纤维化(CF)人群中的患病率接近100%。CRS与CF患者的显著发病相关,包括引发肺部加重的能力。CF患者的CRS通常由儿科医生、耳鼻喉科医生和肺科医生管理。本调查评估了专科医生对CF患者CRS治疗模式的差异。
这是一项横断面电子调查,儿科、耳鼻喉科和肺科多学科团队采用最大变异目的抽样法,以选择对CF患者CRS有专业知识的调查人群。该调查于2019年9月至10月分发给381名从业者。
175名参与者回复(回复率45%)。(54条陈述中的)10条陈述达成了75%的共识。共识陈述包括:CF患者CRS的手术干预决策采用多学科方法(94%;n = 146);最大程度的药物治疗应包括鼻腔盐水冲洗(93%;n = 142)、局部用类固醇(75%;n = 117),最大程度的药物治疗不应包括静脉用类固醇(79%;n = 122);所有涉及额窦的手术(77%;n = 43)和所有翻修手术(80%,n = 45)在手术中都需要影像引导;CF患者鼻窦手术的合适环境因患者表现而异(89%;n = 133);术后方案应包括鼻腔盐水(93%;n = 137);但确实取决于术中发现的疾病严重程度(84%;n = 124);术后抗生素应根据术中培养数据来指导(82%;n = 121)。
专科医生在CF患者CRS治疗方面存在很大差异,然而有10条陈述符合共识标准,在为该人群制定临床护理指南时应予以考虑。